• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内脏脂肪与肝硬化门静脉血栓形成有关。

Visceral fat is associated with cirrhotic portal vein thrombosis.

机构信息

Gastroenterology, Liver Unit, Hospital Universitario Puerta de Hierro-Majadahonda, IDIPHISA, CIBERehd, Madrid, Spain.

出版信息

Expert Rev Gastroenterol Hepatol. 2019 Oct;13(10):1017-1022. doi: 10.1080/17474124.2019.1651644. Epub 2019 Aug 8.

DOI:10.1080/17474124.2019.1651644
PMID:31393183
Abstract

: Central obesity, due to the accumulation of visceral fat(VF), is one of the main risk factors for venous thrombosis. The aim of this study was to determine if VF may be a risk factor for development of portal vein thrombosis(PVT) in cirrhotic patients.: A total of 214 cirrhotic patients at the outpatient clinic were consecutively included, undergoing an anthropometric evaluation, blood tests and bioimpedance.: Median MELDscore was10. Prior liver decompensation occurred in 44.9% of patients and 35.6% of patients had large esophageal varices. Mean body mass index was 28.7 Kg/m2 (39.3%were obese) and mean waist circumference(WC) was 103.8 cm. A 7.5% of patients had PVT at the time of inclusion. PVT was more frequent in males(93.8 vs. 68.2%, p = 0.03). Patients with PVT had a higher WC(111.9 vs. 103.2 cm, p = 0.02) and VF (17.1 vs. 14.5, p = 0.04). PVT was also more frequent in patients with prior decompensation (81.3 vs. 41.9%, p < 0.01) and with large esophageal varices(62.5 vs. 33.3%, p = 0.02). In the simplified multivariate analysis, PVT was independently associated with the presence of portal hypertension(OR 13, 95%CI 1.6-108.3, p = 0.02) and VF(OR 1.2, 95%CI 1.03-1.3, p = 0.01).: VF was independently associated with PVT in cirrhotic patients. VF may be more reliable than conventional anthropometric measurements for cirrhotic patients.

摘要

: 中心性肥胖,由于内脏脂肪(VF)的积累,是静脉血栓形成的主要危险因素之一。本研究旨在确定VF 是否可能是肝硬化患者门静脉血栓形成(PVT)发展的危险因素。: 共连续纳入 214 名门诊肝硬化患者,进行人体测量评估、血液检查和生物阻抗分析。中位 MELD 评分 10。44.9%的患者发生过先前的肝失代偿,35.6%的患者存在大的食管静脉曲张。平均体重指数为 28.7kg/m2(39.3%为肥胖),平均腰围(WC)为 103.8cm。入组时,7.5%的患者存在 PVT。男性中 PVT 更常见(93.8%比 68.2%,p = 0.03)。PVT 患者的 WC(111.9 比 103.2cm,p = 0.02)和 VF(17.1 比 14.5,p = 0.04)更高。PVT 在先前失代偿的患者(81.3%比 41.9%,p < 0.01)和存在大的食管静脉曲张的患者中更为常见(62.5%比 33.3%,p = 0.02)。在简化的多变量分析中,PVT 与门静脉高压的存在独立相关(OR 13,95%CI 1.6-108.3,p = 0.02)和 VF(OR 1.2,95%CI 1.03-1.3,p = 0.01)。: VF 与肝硬化患者的 PVT 独立相关。VF 可能比传统的人体测量指标更能反映肝硬化患者的情况。

相似文献

1
Visceral fat is associated with cirrhotic portal vein thrombosis.内脏脂肪与肝硬化门静脉血栓形成有关。
Expert Rev Gastroenterol Hepatol. 2019 Oct;13(10):1017-1022. doi: 10.1080/17474124.2019.1651644. Epub 2019 Aug 8.
2
Central obesity is associated with non-cirrhotic portal vein thrombosis.中心性肥胖与非肝硬化性门静脉血栓形成有关。
J Hepatol. 2016 Feb;64(2):427-432. doi: 10.1016/j.jhep.2015.08.024. Epub 2015 Aug 31.
3
Incidence and clinical presentation of portal vein thrombosis in cirrhotic patients.肝硬化患者门静脉血栓形成的发病率及临床表现
Hepatobiliary Pancreat Dis Int. 2016 Oct;15(5):499-503. doi: 10.1016/s1499-3872(16)60092-9.
4
Portal vein thrombosis in patients with cirrhosis: just a common finding or a predictor of poor outcome?肝硬化患者的门静脉血栓形成:只是一个常见发现还是预后不良的预测指标?
Ann Hepatol. 2016;15(6):902-906. doi: 10.5604/16652681.1222108.
5
Prevalence and clinical characteristics of advanced portal vein thrombosis in cirrhotic patients with gastroesophageal variceal hemorrhage.肝硬化合并食管胃静脉曲张出血患者中晚期门静脉血栓形成的患病率及临床特征。
J Dig Dis. 2023 Apr;24(4):284-292. doi: 10.1111/1751-2980.13194. Epub 2023 Jun 27.
6
Risk factors associated with portal vein thrombosis in liver cirrhosis: A case-control study.肝硬化门静脉血栓形成的相关危险因素:一项病例对照研究。
Ter Arkh. 2019 Mar 18;91(2):73-81. doi: 10.26442/00403660.2019.02.000153.
7
The use of nonselective beta blockers is a risk factor for portal vein thrombosis in cirrhotic patients.在肝硬化患者中,使用非选择性β受体阻滞剂是门静脉血栓形成的一个危险因素。
Saudi J Gastroenterol. 2018 Jan-Feb;24(1):25-29. doi: 10.4103/sjg.SJG_100_17.
8
Platelet Activation is Upregulated in Cirrhotic Patients with Portal Vein Thrombosis.肝硬化门静脉血栓形成患者血小板活化上调。
Thromb Haemost. 2024 Aug;124(8):739-752. doi: 10.1055/a-2190-8705. Epub 2023 Oct 12.
9
Bacterial infections as a risk factor for non-neoplastic portal vein thrombosis development in cirrhotic patients.细菌感染是肝硬化患者非肿瘤性门静脉血栓形成的危险因素。
Dig Liver Dis. 2024 Mar;56(3):477-483. doi: 10.1016/j.dld.2023.09.012. Epub 2023 Sep 29.
10
[Clinical features of liver cirrhosis complicated by portal vein thrombosis and related risk factors].肝硬化合并门静脉血栓形成的临床特征及相关危险因素
Zhonghua Gan Zang Bing Za Zhi. 2016 Jul 20;24(7):513-517. doi: 10.3760/cma.j.issn.1007-3418.2016.07.006.

引用本文的文献

1
Metabolic Disorders and Risk of Portal Vein Thrombosis in Liver Cirrhosis: A Systematic Review and Meta-Analysis.代谢紊乱与肝硬化门静脉血栓形成风险:系统评价和荟萃分析。
Turk J Gastroenterol. 2022 Jul;33(7):541-553. doi: 10.5152/tjg.2022.211022.
2
Nomogram Model for Prediction of Portal Vein Thrombosis in Patients with Liver Cirrhosis After Splenectomy: A Retrospective Analysis of 2 Independent Cohorts.肝硬化患者脾切除术后门静脉血栓形成的预测列线图模型:两项独立队列的回顾性分析。
Med Sci Monit. 2021 Jun 2;27:e929844. doi: 10.12659/MSM.929844.
3
Interacting hepatic PAI-1/tPA gene regulatory pathways influence impaired fibrinolysis severity in obesity.
交互作用的肝 PAI-1/tPA 基因调控途径影响肥胖患者纤溶活性受损的严重程度。
J Clin Invest. 2020 Aug 3;130(8):4348-4359. doi: 10.1172/JCI135919.